Panacea Biotec, India’s third largest biotechnology company will set up an anti-cancer facility at Baddi with a total cost of Rs 50 crore, this anti-cancer facility will be operational by end of this year. Its capacity is expected to be around 1.2 million vials annually.
Recently, Panacea Biotec had launched book 'PREVENT - Diabetes & Complications in India: Perspective and Treatment Options'. PREVENT, 1st time in India, is a book that attempts to address management guidelines of diabetes and complications based on Indian perspective.
Panacea Biotec is one of India’s leading research based health management companies with established research, manufacturing and marketing capabilities.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1679.85 |
| Dr. Reddys Lab | 1333.05 |
| Cipla | 1305.85 |
| Zydus Lifesciences | 947.10 |
| Lupin | 2340.20 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: